About
ALIVE is a pioneer mid-to-late stage HealthTech fund leveraging an exclusive ecosystem of strategic partners comprising leading hospital chains, HMOs and financial institutions to support and accelerate portfolio companies clinical and commercial expansion. Our unique strategic ecosystem and teams active engagement help portfolio companies realize their full potential and achieve large-scale success. By providing unparalleled access to invaluable resources in the form of: Clinical infrastructures KOLs Big data Domain experts Financial backing we help our companies gain an in-depth understanding of clinical workflows and procedures, to ensure product-market fit under challenging health economics, deliver better care for patients and create value to all stake holders.
Key facts
- Website
- alivevc.com
- Type
- Venture Capital
- Headquarters
- Tel Aviv, Israel
- Funds raised
- $150M
- Portfolio companies
- 11
- Stages
- Pre-SeedSeries ASeries BSeries C
- Cheque size
- $2M to $105M
- Sector focus
- HealthcareCyber RiskCybersecurityIoTMedical Device
Recent investments
| Date | Company | Round | Amount |
|---|---|---|---|
| 26 Mar 2025 | Navina | Series C | $55M |
| 23 Jul 2024 | Magenta Medical | Series D | $105M |
| 14 Feb 2024 | Vessi Medical | Series A | $17M |
| 29 Aug 2023 | Nevia Bio | Seed | $3M |
| 6 Jul 2023 | 538025 | Series A | $4M |
| 3 May 2023 | Magenta Medical | Series C | $55M |
| 9 Jan 2023 | Wisdo Health | Series A | $5M |
| 27 Oct 2022 | Navina | Series B | $22M |
| 10 May 2022 | Oncohost | Series C | $35M |
| 20 Mar 2022 | Nevia Bio | Pre-Seed | $2M |
Frequently asked
What companies has Alive Israel HealthTech Fund invested in?
Alive Israel HealthTech Fund has invested in Navina, Magenta Medical, Vessi Medical, Nevia Bio, 538025 and 6 more.

